VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: Potential role in suppression of myoblast proliferation

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 4, 2012, Pages

  Srikuea, Ratchakrit ^a,b   Zhang, Xiping ^a   Park Sarge, Ok Kyong ^a   Esser, Karyn A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

1 ,25(OH) 2D 3; 1 hydroxylase; 25(OH)D 3; Muscle regeneration; Vitamin D receptor

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 27B1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; GROWTH INHIBITION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKELETAL MUSCLE REGENERATION; UPREGULATION; WESTERN BLOTTING;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BASE SEQUENCE; CALCIFEDIOL; CALCITRIOL; CELL LINE; CELL PROLIFERATION; DNA; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; REGENERATION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84865131204     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00014.2012     Document Type: Article

References (35)

1. 3 levels. Bone 36: 654-662, 2005.
2. 3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol 119: 73-83, 2010.
3. 3. Bone 40: 1517-1528, 2007.
4. Bikle DD. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 21: 375-384, 2010.
5. 3 receptor in human skeletal muscle tissue. Histochem J 33: 19-24, 2001.
6. 3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
7. 3 in C2C12 skeletal muscle cells. Mol Cell Endocrinol 339: 81-89, 2011.
8. Buitrago C, Vazquez G, De Boland AR, Boland RL. Activation of Src kinase in skeletal muscle cells by 1, 1α,25-[OH(2)]-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. J Cell Biochem 79: 274-281, 2000.
9. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 86: 128-135, 2002.
10. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 7: 59-64, 2007.
11. Downes M, Mynett-Johnson L, Muscat GE. The retinoic acid and retinoid X receptors are differentially expressed during myoblast differentiation. Endocrinology 134: 2658-2661, 1994.
12. 3 suppresses the bone-related Runx2/ Cbfa1 gene promoter. Exp Cell Res 274: 323-333, 2002.
13. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144: 5138-5144, 2003.
14. 3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152: 2976-2986, 2011.
15. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75: 611-615, 2002.
16. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr 136: 887-892, 2006.
17. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 51: 1762-1767, 2003.
18. Latham NK, Anderson CS, Lee A, Bennett DA, Moseley A, Cameron ID. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 51: 291-299, 2003.
19. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 92: 4-8, 2006.
20. Lou YR, Molnar F, Perakyla M, Qiao S, Kalueff AV, St-Arnaud R, Carlberg C, Tuohimaa P. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118: 162-170, 2010.
21. 3 on breast cancer cells. J Steroid Biochem Mol Biol 113: 227-232, 2009.
22. McCarthy JJ, Mula J, Miyazaki M, Erfani R, Garrison K, Farooqui AB, Srikuea R, Lawson BA, Grimes B, Keller C, Van Zant G, Campbell KS, Esser KA, Dupont-Versteegden EE, Peterson CA. Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development 138: 3657-3666, 2011.
23. 3 1alpha-hydroxylase from rat kidney mitochondria. FEBS Lett 419: 45-48, 1997.
24. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20: 315-322, 2009.
25. Prufer K, Barsony J. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol 16: 1738-1751, 2002.
26. 3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology 150: 2046-2054, 2009.
27. 3 receptors and activities in muscle. J Biol Chem 260: 8882-8891, 1985.
28. Srikuea R, Esser KA, Pholpramool C. Leukaemia inhibitory factor is expressed in rat gastrocnemius muscle after contusion and increases proliferation of rat L6 myoblasts via c-Myc signalling. Clin Exp Pharmacol Physiol 38: 501-509, 2011.
29. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 494: 166-177, 2010.
30. Wang Y, DeLuca HF. Is the vitamin d receptor found in muscle? Endocrinology 152: 354-363, 2011.
31. Wu-Wong JR, Chen YW, Nakane M, Wolf M. Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. Cardiovasc Drugs Ther 25: 215-222, 2011.
32. Zanello SB, Collins ED, Marinissen MJ, Norman AW, Boland RL. Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm Metab Res 29: 231-236, 1997.
33. 3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10: 2465-2473, 1999.
34. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
35. Zhang X, Patel SP, McCarthy JJ, Rabchevsky AG, Goldhamer DJ, Esser KA. A noncanonical E-box within the MyoD core enhancer is necessary for circadian expression in skeletal muscle. Nucleic Acids Res 40: 3419-3430, 2011.